Daily Values

Growth Metrics

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)Income from Continuing Operations Income towards Parent Company Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Non Operating Income Profit After Tax Research & Development Revenue Selling, General & Administrative Shares Outstanding Shares Outstanding (Weighted Average)

Others

Ratios

Compass Therapeutics (CMPX) Interest & Investment Income (2023)

Compass Therapeutics' Interest & Investment Income history spans 1 years, with the latest figure at $2.0 million for Q4 2023.